MCHP
Price
$73.11
Change
-$0.94 (-1.27%)
Updated
Jul 15 closing price
Capitalization
39.46B
20 days until earnings call
SAVA
Price
$2.07
Change
-$0.09 (-4.17%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
99.51M
15 days until earnings call
Interact to see
Advertisement

MCHP vs SAVA

Header iconMCHP vs SAVA Comparison
Open Charts MCHP vs SAVABanner chart's image
Microchip Technology
Price$73.11
Change-$0.94 (-1.27%)
Volume$6.02M
Capitalization39.46B
Cassava Sciences
Price$2.07
Change-$0.09 (-4.17%)
Volume$7.46K
Capitalization99.51M
MCHP vs SAVA Comparison Chart in %
Loading...
MCHP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCHP vs. SAVA commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCHP is a Hold and SAVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (MCHP: $73.11 vs. SAVA: $2.06)
Brand notoriety: MCHP: Notable vs. SAVA: Not notable
MCHP represents the Semiconductors, while SAVA is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCHP: 69% vs. SAVA: 53%
Market capitalization -- MCHP: $39.46B vs. SAVA: $99.51M
MCHP [@Semiconductors] is valued at $39.46B. SAVA’s [@Biotechnology] market capitalization is $99.51M. The market cap for tickers in the [@Semiconductors] industry ranges from $4.16T to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Semiconductors] industry is $62.01B. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCHP’s FA Score shows that 0 FA rating(s) are green whileSAVA’s FA Score has 0 green FA rating(s).

  • MCHP’s FA Score: 0 green, 5 red.
  • SAVA’s FA Score: 0 green, 5 red.
According to our system of comparison, MCHP is a better buy in the long-term than SAVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCHP’s TA Score shows that 2 TA indicator(s) are bullish while SAVA’s TA Score has 6 bullish TA indicator(s).

  • MCHP’s TA Score: 2 bullish, 5 bearish.
  • SAVA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SAVA is a better buy in the short-term than MCHP.

Price Growth

MCHP (@Semiconductors) experienced а -1.94% price change this week, while SAVA (@Biotechnology) price change was -0.96% for the same time period.

The average weekly price growth across all stocks in the @Semiconductors industry was +0.94%. For the same industry, the average monthly price growth was +12.55%, and the average quarterly price growth was +2.95%.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

MCHP is expected to report earnings on Oct 30, 2025.

SAVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Semiconductors (+0.94% weekly)

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

@Biotechnology (+2.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MCHP($39.5B) has a higher market cap than SAVA($99.5M). MCHP YTD gains are higher at: 29.431 vs. SAVA (-12.712). MCHP has higher annual earnings (EBITDA): 1.04B vs. SAVA (-145.89M). MCHP has more cash in the bank: 772M vs. SAVA (117M). SAVA has less debt than MCHP: SAVA (0) vs MCHP (5.67B). MCHP has higher revenues than SAVA: MCHP (4.4B) vs SAVA (0).
MCHPSAVAMCHP / SAVA
Capitalization39.5B99.5M39,698%
EBITDA1.04B-145.89M-713%
Gain YTD29.431-12.712-232%
P/E Ratio86.21N/A-
Revenue4.4B0-
Total Cash772M117M660%
Total Debt5.67B0-
FUNDAMENTALS RATINGS
MCHP vs SAVA: Fundamental Ratings
MCHP
SAVA
OUTLOOK RATING
1..100
708
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3855
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAVA's Valuation (22) in the Pharmaceuticals Other industry is in the same range as MCHP (50) in the Semiconductors industry. This means that SAVA’s stock grew similarly to MCHP’s over the last 12 months.

MCHP's Profit vs Risk Rating (67) in the Semiconductors industry is somewhat better than the same rating for SAVA (100) in the Pharmaceuticals Other industry. This means that MCHP’s stock grew somewhat faster than SAVA’s over the last 12 months.

SAVA's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as MCHP (100) in the Semiconductors industry. This means that SAVA’s stock grew similarly to MCHP’s over the last 12 months.

MCHP's Price Growth Rating (38) in the Semiconductors industry is in the same range as SAVA (55) in the Pharmaceuticals Other industry. This means that MCHP’s stock grew similarly to SAVA’s over the last 12 months.

MCHP's P/E Growth Rating (100) in the Semiconductors industry is in the same range as SAVA (100) in the Pharmaceuticals Other industry. This means that MCHP’s stock grew similarly to SAVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCHPSAVA
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MCHP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FPA36.25-0.20
-0.55%
First Trust AsiaPac ex-Jpn AlphaDEX® ETF
RSPU71.37-0.57
-0.79%
Invesco S&P 500® Equal Weight Utilts ETF
EWC46.04-0.40
-0.86%
iShares MSCI Canada ETF
FBCV32.50-0.44
-1.35%
Fidelity Blue Chip Value ETF
HEAL10.38-0.15
-1.42%
Global X HealthTech ETF